BibTex RIS Cite

Relationship Between 24-Hour Urine and Serum Parameters in Patients with Nephrolithiasis

Year 2007, Volume: 12 Issue: 1, 37 - 40, 01.02.2007

Abstract

Objective: Nephrolithiasis is a common disease, whereas the mechanisms by which stones develop in the kidney are poorly understood. While high levels of oxalate, uric acid, calcium, and phosphate in the urine increase the formation of nephrolithiasis, increased urinary excretion of citrate, magnesium, albumin and alkali urine decrease this process. In this study, we aimed to identify the possible relationship between some serum and 24- hour urinary parameters in patients with nephrolithiasis. Materials and Methods: Two hundreds thirty-one patients with nephrolithiasis (aged 18-65 years; 143 men, 88 women) were retrospectively examined in this study. Results: Significant correlations observed between urine and serum levels of creatinine with urine and serum levels of uric acid [r= 0.70, (p

References

  • Parks YJ, Coe LF: The financial effects of kidney stone prevention. Kidney International. 1996; 50: 1706-1712
  • Bisaz S, Felix R., Newman WF, Fleisch H: Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min Electrolyte Metab. 1978; 1:74
  • Tiselius HG: Urinary Excretion of Citrate in Normal Subjects and Patients with Urolithiasis. Plenum Press, New York, 1981
  • Welshman SG, Mc Geown MG: Urinary citrate excretion in stone-formers and normal controls. Br J Urol. 1976; 48: 7-11
  • Hodgkinson A: Citric Acid Excretion of Citrate in Normal Adults and in Patients with Renal Calculus. Clin Sci. 1962; 23: 203-212
  • Elliot JS, Riberio ME: The urinary excretion of citric, hippuric and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease. Invest Urol. 1972; 10: 102-106
  • Sehwille PO, Scholz D, Paulus M, Engelhardt W, Sigel A:. Citrate in Daily and fasting urine. Invest Urol. 1979; 16: 457-462
  • Robertson WG, Peacock M, Nordin BEC: Activity products in stone-forming urine. Clin Sci.1968; 32: 579-594
  • Welshman SG, Mc Geown MG: A quantitative investigation of the effects on the growth of calcium oxalate crystals of potential inhibitors. Br J Urol. 1972; 44: 677-680
  • Pylypchuk G, Ehrig U, Wilson DR: Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation. Can Med Assoc. J, 1979; 17: 658-665
  • Butz M: Oxalatsteinprophylaxe durch alkali-theriape. Urologe. 1982; 21: 142-146
  • Rudman D, Kutner MH, Redol SC, Waters WC, Gerron GG, Bleier J: Hypocitraturia in calcium nephrolithiasis. J Clin Endocrnol Metab. 1982; 55: 1052-1057
  • Nicar MJ, Skurla C, Sakhaec K, Pak CYC: Low urinary citrate excretion in nephrolithiasis. Urology. 1983; 21: 8-14
  • Menon M., Mahle CJ: Urinary citrate excretion in patients renal calculi. J Urol. 1983; 129: 1158-1160
  • Millan A, Conte A, Garcia Raso A, Grases F: Determination of Citrate in urine by simple direct photometry. Clin Chem. 1987; 33: 1259-1260
  • Robertson WG, Peacock M, Nordin BEC: Activity products in stone-forming and non stone-forming urine. Clin Sci. 1968; 32: 579-594
  • Robertson WG, Peacock M, Nordin BEC: Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci. 1971; 40: 365-374
  • Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB: Risk factors in calcium stone disease of the urinary tract. Br J Urol.1978; 50: 449-454
  • Marshall RW, Barry HH: Urine Saturation and the formation of calcium Containing Calculi. The effects of various forms of therapy. Karger, Basel 1973
  • Fellstrom B, Backman U, Danielson BG, Johansson G, Ljunghall S, Wikstrom B: Urinary excretion of urate in renal calcium stone disease and tubular acidification disturbances. J Urol. 1982; 127: 589-592
  • Dumoulin G, Haton D, Wolf JP, Henriet MT, Nguyen NU, Mougin C, Saint-Hiller Y, Combes M, Berthelay S: Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis. Nephrologie. 1984; 5: 189-191
  • Duranti E, Imperiali P, Badi M, Capiccioni S, Masi MG, Sasdelli M: Study of inhibitor and nucleator activities in calcium stone former. Proc Eur Dial Transplant Assoc. 1983; 20: 445-449
  • Conte A, Roca P, Gianotti M, Grases F: On the relation between citrate and calcium in normal and stone-former subjects. Int Urol Nephrol. 1990; 22: 7-12
  • Oehlschlager S, Albrecht S, Hakenberg OW, Schrodter S, Froehner M, Manseck A, Wirth MP: Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy. Adult Urology 2003;62: 17-21
  • Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M: Metabolic Risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int. 2003; 70: 273-277
  • Ogawa Y, Yonou H, Hokama S, Oda M, Moruzumi M, Sugaya K: Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens. Front Biosci. 2003; 8: A167-A176
  • Scholz D, Schwille PO, Ulbrich D, Bausch WM, Sigel A: Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res. 1979; 7: 161-170.

Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki

Year 2007, Volume: 12 Issue: 1, 37 - 40, 01.02.2007

Abstract

Amaç: Nefrolitiazis yaygın bir hastalık olmasına rağmen, böbrekteki taş oluşum mekanizması tam olarak anlaşılamamıştır. İdrarda yüksek konsantrasyonda oksalat, ürik asit, kalsiyum ve fosfor bulunması nefrolitiazis oluşma riskini arttırırken; sitrat, magnezyum, albumin düzeylerinin yüksekliği ve idrarın alkali olması ise bu riski azaltmaktadır. Bu çalışmada nefrolitiasizli hastalarda serum ve 24 saatlik idrar analizi sonucu elde edilen parametreler arasındaki muhtemel ilişkiyi tespit etmeyi amaçladık. Gereç ve Yöntem: 231 adet nefrolitiazisli hasta (18-65 yaşları arasında; 143 erkek, 88 kadın)retrospektif olarak incelendi. Bulgular: İdrar ve serum kreatinin değerleri ile idrar ve serum ürik asit değerleri arasında [sırasıyla r= 0.70, (p

References

  • Parks YJ, Coe LF: The financial effects of kidney stone prevention. Kidney International. 1996; 50: 1706-1712
  • Bisaz S, Felix R., Newman WF, Fleisch H: Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min Electrolyte Metab. 1978; 1:74
  • Tiselius HG: Urinary Excretion of Citrate in Normal Subjects and Patients with Urolithiasis. Plenum Press, New York, 1981
  • Welshman SG, Mc Geown MG: Urinary citrate excretion in stone-formers and normal controls. Br J Urol. 1976; 48: 7-11
  • Hodgkinson A: Citric Acid Excretion of Citrate in Normal Adults and in Patients with Renal Calculus. Clin Sci. 1962; 23: 203-212
  • Elliot JS, Riberio ME: The urinary excretion of citric, hippuric and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease. Invest Urol. 1972; 10: 102-106
  • Sehwille PO, Scholz D, Paulus M, Engelhardt W, Sigel A:. Citrate in Daily and fasting urine. Invest Urol. 1979; 16: 457-462
  • Robertson WG, Peacock M, Nordin BEC: Activity products in stone-forming urine. Clin Sci.1968; 32: 579-594
  • Welshman SG, Mc Geown MG: A quantitative investigation of the effects on the growth of calcium oxalate crystals of potential inhibitors. Br J Urol. 1972; 44: 677-680
  • Pylypchuk G, Ehrig U, Wilson DR: Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation. Can Med Assoc. J, 1979; 17: 658-665
  • Butz M: Oxalatsteinprophylaxe durch alkali-theriape. Urologe. 1982; 21: 142-146
  • Rudman D, Kutner MH, Redol SC, Waters WC, Gerron GG, Bleier J: Hypocitraturia in calcium nephrolithiasis. J Clin Endocrnol Metab. 1982; 55: 1052-1057
  • Nicar MJ, Skurla C, Sakhaec K, Pak CYC: Low urinary citrate excretion in nephrolithiasis. Urology. 1983; 21: 8-14
  • Menon M., Mahle CJ: Urinary citrate excretion in patients renal calculi. J Urol. 1983; 129: 1158-1160
  • Millan A, Conte A, Garcia Raso A, Grases F: Determination of Citrate in urine by simple direct photometry. Clin Chem. 1987; 33: 1259-1260
  • Robertson WG, Peacock M, Nordin BEC: Activity products in stone-forming and non stone-forming urine. Clin Sci. 1968; 32: 579-594
  • Robertson WG, Peacock M, Nordin BEC: Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci. 1971; 40: 365-374
  • Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB: Risk factors in calcium stone disease of the urinary tract. Br J Urol.1978; 50: 449-454
  • Marshall RW, Barry HH: Urine Saturation and the formation of calcium Containing Calculi. The effects of various forms of therapy. Karger, Basel 1973
  • Fellstrom B, Backman U, Danielson BG, Johansson G, Ljunghall S, Wikstrom B: Urinary excretion of urate in renal calcium stone disease and tubular acidification disturbances. J Urol. 1982; 127: 589-592
  • Dumoulin G, Haton D, Wolf JP, Henriet MT, Nguyen NU, Mougin C, Saint-Hiller Y, Combes M, Berthelay S: Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis. Nephrologie. 1984; 5: 189-191
  • Duranti E, Imperiali P, Badi M, Capiccioni S, Masi MG, Sasdelli M: Study of inhibitor and nucleator activities in calcium stone former. Proc Eur Dial Transplant Assoc. 1983; 20: 445-449
  • Conte A, Roca P, Gianotti M, Grases F: On the relation between citrate and calcium in normal and stone-former subjects. Int Urol Nephrol. 1990; 22: 7-12
  • Oehlschlager S, Albrecht S, Hakenberg OW, Schrodter S, Froehner M, Manseck A, Wirth MP: Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy. Adult Urology 2003;62: 17-21
  • Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M: Metabolic Risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int. 2003; 70: 273-277
  • Ogawa Y, Yonou H, Hokama S, Oda M, Moruzumi M, Sugaya K: Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens. Front Biosci. 2003; 8: A167-A176
  • Scholz D, Schwille PO, Ulbrich D, Bausch WM, Sigel A: Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res. 1979; 7: 161-170.
There are 27 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Hüsamettin Erdamar This is me

Banu Sancak This is me

Neslihan Bukan This is me

Hatice Paşaoğlu This is me

Publication Date February 1, 2007
Published in Issue Year 2007 Volume: 12 Issue: 1

Cite

APA Erdamar, H., Sancak, B., Bukan, N., Paşaoğlu, H. (2007). Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki. Fırat Tıp Dergisi, 12(1), 37-40.
AMA Erdamar H, Sancak B, Bukan N, Paşaoğlu H. Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki. Fırat Tıp Dergisi. February 2007;12(1):37-40.
Chicago Erdamar, Hüsamettin, Banu Sancak, Neslihan Bukan, and Hatice Paşaoğlu. “Nefrolitiazisli Hastalarda 24 Saatlik İdrar Ve Serum Parametreleri Arasında İlişki”. Fırat Tıp Dergisi 12, no. 1 (February 2007): 37-40.
EndNote Erdamar H, Sancak B, Bukan N, Paşaoğlu H (February 1, 2007) Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki. Fırat Tıp Dergisi 12 1 37–40.
IEEE H. Erdamar, B. Sancak, N. Bukan, and H. Paşaoğlu, “Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki”, Fırat Tıp Dergisi, vol. 12, no. 1, pp. 37–40, 2007.
ISNAD Erdamar, Hüsamettin et al. “Nefrolitiazisli Hastalarda 24 Saatlik İdrar Ve Serum Parametreleri Arasında İlişki”. Fırat Tıp Dergisi 12/1 (February 2007), 37-40.
JAMA Erdamar H, Sancak B, Bukan N, Paşaoğlu H. Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki. Fırat Tıp Dergisi. 2007;12:37–40.
MLA Erdamar, Hüsamettin et al. “Nefrolitiazisli Hastalarda 24 Saatlik İdrar Ve Serum Parametreleri Arasında İlişki”. Fırat Tıp Dergisi, vol. 12, no. 1, 2007, pp. 37-40.
Vancouver Erdamar H, Sancak B, Bukan N, Paşaoğlu H. Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki. Fırat Tıp Dergisi. 2007;12(1):37-40.